Skip to main content
Log in

Economic Evaluation of an Educational Campaign for Early Diagnosis of Cutaneous Melanoma

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Public educational campaigns for the early diagnosis of cutaneous melanoma are considered an effective approach in the prevention of this disease, since they increase the number of cases detected early and consequently lengthen patients’ life expectancy. We performed an economic evaluation of such a campaign in Bergamo, Italy, in order to quantify its costs and consequences.

We used cost-effectiveness analysis to compare the costs and effects of the campaign with those of the ‘do nothing’ option. The analysis was performed from the perspective of the Italian National Health Service [the Servizio Sanitario Nazionale (SSN)]. Accordingly, only direct costs related to publicly financed healthcare services were considered. No indirect costs or benefits were considered because they are not relevant to the SSN. Incremental analysis was used to obtain results in terms of additional costs per life-year saved (LYS). Overall LYS were quantified by comparing the survival curves for 4 subgroups of patients with different lesional thicknesses at diagnosis (<0.76mm, 0.76 to 1.50mm, 1.51 to 3.00mm and>3.00mm). All costs were estimated in 1993 Italian lire (L).

Overall effectiveness amounted to 233.49 LYS. Using a 5% discount rate, the value of effectiveness was 171.3 LYS. The total cost of the educational campaign (i.e. the sum of the organisational and ‘induced’ costs minus the costs saved) was estimated at L817 million (approximate 1993 exchange rate $US1 = LI573), and L905 million after discounting at a rate of 5%. Thus, using discounted cost and effectiveness data, the cost of the educational campaign was L5.28 million per LYS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balch CM, Houghton AN, Peters LJ. Cutaneous melanoma. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: J.B. Lippincott Co., 1993: 1612–61

    Google Scholar 

  2. McLeod GR, David NC, Little JH, et al. Melanoma in Queensland, Australia: experience in the Queensland Melanoma Project. In: Balch CM, Milton GW, editors. Cutaneous melanoma: clinical management and treatment results worldwide. Philadelphia: J.B. Lippincott Co., 1985: 379–87

    Google Scholar 

  3. Roush GC, Schymurs M, Holford TR. Risk for cutaneous melanoma in recent Connecticut birth cohorts. Am J Public Health 1985; 75: 679–82

    Article  PubMed  CAS  Google Scholar 

  4. Redman JC, Mora DB. Malignant melanomas of the skin diagnosed and treated in Albuquerque, New Mexico in 1980. J Dermatol Surg Oncol 1982; 8: 40–3

    PubMed  CAS  Google Scholar 

  5. Bonett A, Roder D, Esterman A. Melanoma case survival rates in South Australia by histological type, thickness and level of tumor at diagnosis. Med J Aust 1986; 144: 680–2

    PubMed  CAS  Google Scholar 

  6. Grin-Jorgensen CM, Rigel DS, Friedman RJ. The worldwide incidence of malignant melanoma. In: Balch CM, Houghton AN, Milton GW, et al., editors. Cutaneous melanoma. 2nd ed. Philadelphia: J.B. Lippincott Co., 1992: 27–39

    Google Scholar 

  7. Rigel DS, Kopf AW, Friedman RJ. The worldwide incidence of malignant melanoma in the US: are we making an impact? J Am Acad Dermatol 1987; 17: 1050–3

    Article  PubMed  CAS  Google Scholar 

  8. Johnson TM, Smith JW, Nelson BR, et al. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995; 32: 689–707

    Article  PubMed  CAS  Google Scholar 

  9. Lee JAH. The causation of melanoma. In: Balch CM, Milton GW, editors. Cutaneous melanoma: clinical management and treatment results worldwide. Philadelphia: J.B. Lippincott Co., 1985: 303–11

    Google Scholar 

  10. Armstrong BK, English DR. Epidemiologic studies. In: Balch CM, Houghton AN, Milton GW, et al., editors. Cutaneous melanoma. 2nd ed. Philadelphia: J.B. Lippincott Co., 1992: 12–26

    Google Scholar 

  11. Newell GR. Is ultraviolet irradiation the sole cause of melanoma? Melanoma Lett 1987; 5: 4

    Google Scholar 

  12. McCarthy WH, Shaw HM. Skin cancer in Australia. Med J Aust 1989; 150: 469–70

    PubMed  CAS  Google Scholar 

  13. MacKie R, Hunter JAA, Altchison TC, et al. Cutaneous malignant melanoma. Lancet 1992; 339: 971–5

    Article  PubMed  CAS  Google Scholar 

  14. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987

    Google Scholar 

  15. Drummond MF. Principles of economic appraisal in health care. Oxford: Oxford University Press, 1980

    Google Scholar 

  16. Garattini L. Italian health care reform. York: University of York, 1992

    Google Scholar 

  17. Cainelli T, Imberti GL, Tribbia G, et al. 1996: campagna di educazione sanitaria per la diagnosi precoce del melanoma nella provincia di Bergamo. G Ital Dermatol. In press

  18. Bernengo MG, Doveil GC, Lisa F, et al. Melanoma cutaneo nel Centro Melanomi di Torino: sopravvivenza e correlazione con i fattori prognostici clinici ed istologici in 502 pazienti in stadio I (1975–1985). G Ital Dermatol Venereol 1986; 121(5): 311–26

    PubMed  CAS  Google Scholar 

  19. GIPME (Gruppo Italiano Polidisciplinare sul Melanoma). II melanoma cutaneo: protocollo di diagnosi e terapia. Milan: GIPME, 1991

    Google Scholar 

  20. Cascinelli N, Morabito A, Bufalino R, et al. Prognosis of stage I melanoma of the skin. Int J Cancer 1980; 26: 733–9

    Article  Google Scholar 

  21. Veronesi U, Cascinelli N. Narrow excision (1 cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991; 126: 438–41

    Article  PubMed  CAS  Google Scholar 

  22. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 31: 716–21

    Article  Google Scholar 

  23. Keeler EB, Cretin S. Discounting of life-savings and other non-monetary effects. Manag Sci 1983; 29(3): 300–6

    Article  Google Scholar 

  24. Decreto Ministero della Sanità n. 80 del 7/11/91. Revisione del nomenclatore tariffario delle prestazioni specialistiche ambulatoriali: supplemento ordinario della Gazzetta Ufficiale della Repubblica Italiana, n. 286 del 6/12/91 — Serie Generale

  25. Garattini L, Grilli R, Scopelliti D, et al. A proposal for Italian guidelines in pharmacoeconomics. PharmacoEconomics 1995; 7(1): 1–6

    Article  PubMed  CAS  Google Scholar 

  26. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95–104

    Article  PubMed  CAS  Google Scholar 

  27. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical decision analysis. Philadelphia: WB Saunders, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garattini, L., Cainelli, T., Tribbia, G. et al. Economic Evaluation of an Educational Campaign for Early Diagnosis of Cutaneous Melanoma. Pharmacoeconomics 9, 146–155 (1996). https://doi.org/10.2165/00019053-199609020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199609020-00006

Keywords

Navigation